News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
594,469 Results
Type
Article (55279)
Company Profile (176)
Press Release (539014)
Multimedia
Podcasts (62)
Webinars (11)
Section
Business (174602)
Career Advice (1649)
Deals (29527)
Drug Delivery (84)
Drug Development (68479)
Employer Resources (116)
FDA (11988)
Job Trends (12380)
News (289327)
Policy (24873)
Tag
Academia (2682)
Academic (1)
Accelerated approval (4)
Adcomms (14)
Allergies (65)
Alliances (44833)
ALS (80)
Alzheimer's disease (1257)
Antibody-drug conjugate (ADC) (101)
Approvals (12038)
Artificial intelligence (223)
Autoimmune disease (15)
Automation (9)
Bankruptcy (254)
Best Places to Work (9210)
BIOSECURE Act (13)
Biosimilars (72)
Biotechnology (92)
Bladder cancer (49)
Brain cancer (29)
Breast cancer (225)
Cancer (1884)
Cardiovascular disease (133)
Career advice (1389)
Career pathing (25)
CAR-T (118)
Cell therapy (338)
Cervical cancer (14)
Clinical research (55010)
Collaboration (767)
Compensation (302)
Complete response letters (19)
COVID-19 (2215)
CRISPR (41)
C-suite (216)
Cystic fibrosis (86)
Data (1842)
Decentralized trials (2)
Denatured (23)
Depression (35)
Diabetes (198)
Diagnostics (4962)
Digital health (11)
Diversity (5)
Diversity, equity & inclusion (30)
Drug discovery (106)
Drug pricing (80)
Drug shortages (16)
Duchenne muscular dystrophy (73)
Earnings (69577)
Editorial (27)
Employer branding (18)
Employer resources (103)
Events (87392)
Executive appointments (691)
FDA (12939)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (3)
Frontotemporal dementia (7)
Funding (631)
Gene editing (83)
Generative AI (19)
Gene therapy (256)
GLP-1 (578)
Government (2934)
Grass and pollen (4)
Guidances (54)
Healthcare (14061)
Huntington's disease (12)
IgA nephropathy (16)
Immunology and inflammation (76)
Indications (24)
Infectious disease (2320)
Inflammatory bowel disease (106)
Inflation Reduction Act (6)
Influenza (42)
Intellectual property (82)
Interviews (299)
IPO (13297)
IRA (34)
Job creations (3547)
Job search strategy (1203)
Kidney cancer (8)
Labor market (27)
Layoffs (369)
Leadership (14)
Legal (6163)
Liver cancer (57)
Lung cancer (261)
Lymphoma (136)
Machine learning (6)
Management (37)
Manufacturing (259)
MASH (58)
Medical device (8665)
Medtech (8669)
Mergers & acquisitions (16684)
Metabolic disorders (500)
Multiple sclerosis (63)
NASH (17)
Neurodegenerative disease (67)
Neuropsychiatric disorders (15)
Neuroscience (1704)
NextGen: Class of 2025 (4771)
Non-profit (3936)
Now hiring (28)
Obesity (248)
Opinion (191)
Ovarian cancer (66)
Pain (77)
Pancreatic cancer (69)
Parkinson's disease (125)
Partnered (20)
Patents (179)
Patient recruitment (85)
Peanut (31)
People (51785)
Pharmaceutical (74)
Pharmacy benefit managers (13)
Phase I (16544)
Phase II (23879)
Phase III (18680)
Pipeline (1075)
Policy (111)
Postmarket research (2495)
Preclinical (8060)
Press Release (72)
Prostate cancer (87)
Psychedelics (26)
Radiopharmaceuticals (225)
Rare diseases (313)
Real estate (5344)
Recruiting (44)
Regulatory (17397)
Reports (29)
Research institute (2544)
Resumes & cover letters (237)
Rett syndrome (5)
RNA editing (3)
RSV (22)
Schizophrenia (66)
Series A (95)
Series B (57)
Service/supplier (13)
Sickle cell disease (48)
Special edition (16)
Spinal muscular atrophy (132)
Sponsored (25)
Startups (3075)
State (2)
Stomach cancer (5)
Supply chain (49)
Tariffs (38)
The Weekly (37)
Vaccines (554)
Venture capitalists (24)
Weight loss (150)
Women's health (20)
Worklife (10)
Date
Last 7 days (713)
Last 30 days (2022)
Last 365 days (26491)
2025 (8795)
2024 (28685)
2023 (33163)
2022 (43709)
2021 (47038)
2020 (44497)
2019 (36832)
2018 (28014)
2017 (27799)
2016 (27821)
2015 (33384)
2014 (27156)
2013 (23799)
2012 (24431)
2011 (25233)
2010 (23962)
Location
Africa (740)
Alabama (51)
Alaska (5)
Arizona (146)
Arkansas (7)
Asia (36465)
Australia (6144)
California (4653)
Canada (1807)
China (428)
Colorado (223)
Connecticut (233)
Delaware (109)
Europe (80591)
Florida (742)
Georgia (146)
Idaho (39)
Illinois (440)
India (25)
Indiana (239)
Iowa (7)
Japan (153)
Kansas (87)
Kentucky (22)
Louisiana (10)
Maine (57)
Maryland (640)
Massachusetts (3571)
Michigan (201)
Minnesota (270)
Mississippi (2)
Missouri (70)
Montana (22)
Nebraska (22)
Nevada (48)
New Hampshire (38)
New Jersey (1482)
New Mexico (27)
New York (1405)
North Carolina (838)
North Dakota (7)
Northern California (2044)
Ohio (168)
Oklahoma (10)
Oregon (26)
Pennsylvania (1074)
Puerto Rico (11)
Rhode Island (29)
South America (986)
South Carolina (14)
Southern California (1770)
Tennessee (83)
Texas (700)
United States (18222)
Utah (113)
Virginia (146)
Washington D.C. (52)
Washington State (455)
West Virginia (2)
Wisconsin (57)
594,469 Results for "owc pharmaceutical research corp".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
American Academy of Dermatology Awards Podium Presentation to Phio Pharmaceutical’s Clinical Research at 2025 Annual Meeting
Interim Results from clinical study for cutaneous carcinomas presented at Late-Breaking Research Session
March 10, 2025
·
5 min read
Protect Pharmaceutical Corp. Issues Corporate Update
Protect Pharmaceutical Corp.'s (OTC: PRTT) (“Company”) President, Ali Yildiz, provides its shareholders with the following informational update: “July 1, 2024 Dear Shareholders: The Company’s PCAOB audit for the fiscal year of 2023 is near completion.
July 1, 2024
·
4 min read
Press Releases
180 Life Sciences Corp. Announces Share Repurchase
April 30, 2025
·
7 min read
Layoffs
Entrada Cuts 20% of Workforce, Targeting Research Employees
Entrada is paring back its research staff even as it gears up to hire employees to support a planned clinical trial for a Duchenne muscular dystrophy candidate.
April 30, 2025
·
1 min read
·
Angela Gabriel
Policy
If you purchased OWC Pharmaceutical Research Corp. stock between November 2016 and September 2017, you may be eligible for distribution from the Jeffrey Friedland Fair Fund
If you purchased OWC Pharmaceutical Research Corp. stock between November 2016 and September 2017, you may be eligible for distribution from the Jeffrey Friedland Fair Fund
February 4, 2022
·
4 min read
Press Releases
Tonix Pharmaceuticals Presented Preclinical Data on Gastric Cancer Models at the American Association for Cancer Research (AACR) 2025 Annual Meeting
April 30, 2025
·
12 min read
Press Releases
OrthoPediatrics Corp. Expands Scoliosis Portfolio with Launch of VerteGlide™ System
April 9, 2025
·
2 min read
Press Releases
Turnstone Biologics Corp. Reports Fourth Quarter and Full Year 2024 Financial Results
March 31, 2025
·
4 min read
Press Releases
Maxwell Biosciences Secures US Military Agreement to Research Scientific Aspects of Claromer Technology
U.S. Army Institute of Surgical Research to conduct key studies intended to further our knowledge of the effects of Claromer technology
March 5, 2025
·
2 min read
Press Releases
STX PARTNERS LLP and Newlin Investment Co. Exercise Warrants of Sharp Therapeutics Corp.
April 21, 2025
·
3 min read
1 of 59,447
Next
